This renewal grant responds to BRG PAR-13-1371 for the development of noninvasive and nondestructive imaging methods for in vivo monitoring;novel diagnostic and medical devices;and new bioengineering ap- proaches to cardiovascular treatment. The grant targets atherosclerosis, which in advanced disease, is characterized by lesions with lipids, calcification, and fibrous caps whose rupture are a leading cause of stroke, heart attack and death. While typically diagnosed by X-ray catheterization, X-ray can't assess plaque contents, vulnerability to rupture, or early stage wall-thickening. Our goal is to develop a novel, safe, mini- mally-invasive, fast, high-resolution, cardiovascular imaging modality employing high-field intravascular (IV) magnetic resonance imaging (MRI), to assess and monitor disease, and provide targeted therapy delivery. In the expiring grant period we created novel dosimetry tools for testing the safety of internal devices dur- ing MRI. We showed theoretically and experimentally that the signal-to-noise ratio of internal detectors in- creased with MRI field strength-squared, at least up to 7 Tesla (T). This enabled 80?m IVMRI at 3T and 40- 50?m at 7T to visualize plaque morphology. We developed a new ?-imaging method, 'MRI endoscopy'that provides a stream of images intrinsically locked to the probe's viewpoint at up to 2 fr/s. Because IVMRI resolution at 40-50?m is now within a range that could identify plaques vulnerable to rupture, and because chemically-selective imaging of mobile lipids is also possible at higher MRI fields, the possibility of character- izing key attributes of vulnerable plaque-thin fibrous caps and mobile lipid contents by IVMRI, now exists. But technical issues remain: we need still faster IVMRI, and reduced sensitivity to motion. We need a method of chemically selective IVMRI. We don't know how IVMRI compares with other IV modalities-IV ul- trasound (IVUS) or optical coherence tomography (OCT). And if we see disease, can we intervene? This re- newal addresses all these key questions.
Aim 1 creates a high-speed real-time, motion-insensitive IVMRI capability using novel sparse sampling and frame-shifting methods.
Aim 2 develops high-field 40-50?m IV MRI and chemically-selective lipid imaging to characterize plaque caps and contents.
Aim 3 performs com- parative studies in vitro and in vivo of IVMRI, OCT, and IVUS.
Aim 4 creates an interventional platform for high-resolution IVMRI-targeting, demonstrated for angioplasty, and cellular and ultrasound ablation thera- pies. This project, supported by progress in the 1st grant and new preliminary work, can provide important new IV imaging and interventional tools to advance understanding and treatment of cardiovascular disease.

Public Health Relevance

The goal of this grant is to develop a novel, safe, minimally-invasive, fast, high-resolution, transluminal cardiovascular imaging modality employing intravascular (IV) magnetic resonance imaging (MRI), capable of detecting key chemical and structural factors affecting the vulnerability of atherosclerotic plaques to rupture with consequences that are often dire. It will place IVMRI in the context of other IV imaging modalities, and develop and demonstrate its use for providing precision targeted therapy delivery, pursuant to PAR-13-137.

National Institute of Health (NIH)
Research Project (R01)
Project #
Application #
Study Section
Medical Imaging Study Section (MEDI)
Program Officer
Liu, Guoying
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Johns Hopkins University
Schools of Medicine
United States
Zip Code
Hegde, Shashank Sathyanarayana; Zhang, Yi; Bottomley, Paul A (2015) Acceleration and motion-correction techniques for high-resolution intravascular MRI. Magn Reson Med 74:452-61
Zhang, Yi; Zhou, Jinyuan; Bottomley, Paul A (2015) Minimizing lipid signal bleed in brain (1) H chemical shift imaging by post-acquisition grid shifting. Magn Reson Med 74:320-9
Wang, Guan; El-Sharkawy, AbdEl-Monem M; Bottomley, Paul A (2014) Minimum acquisition methods for simultaneously imaging T(1), T(2), and proton density with B(1) correction and no spin-echoes. J Magn Reson 242:243-55
Owens, Sean; Erturk, M Arcan; Ouanes, Jean-Pierre P et al. (2014) Evaluation of epidural and peripheral nerve catheter heating during magnetic resonance imaging. Reg Anesth Pain Med 39:534-9
Zhang, Yi; Gabr, Refaat E; Zhou, Jinyuan et al. (2013) Highly-accelerated quantitative 2D and 3D localized spectroscopy with linear algebraic modeling (SLAM) and sensitivity encoding. J Magn Reson 237:125-38
Erturk, M Arcan; Bottomley, Paul A; El-Sharkawy, Abdel-Monem M (2013) Denoising MRI using spectral subtraction. IEEE Trans Biomed Eng 60:1556-62
Wang, G; El-Sharkawy, A M; Edelstein, W A et al. (2012) Measuring T? and T?, and imaging T? without spin echoes. J Magn Reson 214:273-80
Ruiz-Cabello, Jesus; Barnett, Brad P; Bottomley, Paul A et al. (2011) Fluorine (19F) MRS and MRI in biomedicine. NMR Biomed 24:114-29
Zhang, Y; Gabr, R E; Schar, M et al. (2011) Encoding of pre-selected compartments produces large SNR and speed advantages for P MRS. Proc Int Soc Magn Reson Med Sci Meet Exhib Int Soc Magn Reson M 19:1438
Qian, Di; El-Sharkawy, AbdEl-Monem M; Atalar, Ergin et al. (2010) Interventional MRI: tapering improves the distal sensitivity of the loopless antenna. Magn Reson Med 63:797-802

Showing the most recent 10 out of 20 publications